WallStSmart
VERO

Venus Concept Inc

NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES

$0.31
+0.00% today

Updated 2026-06-03

Market cap
$578190.00
P/E ratio
P/S ratio
0.01x
EPS (TTM)
$-45.26
Dividend yield
52W range
$0 – $8
Volume
0.0M

Venus Concept Inc (VERO) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-72.49%
Operating margin
-41.93%
ROE
-795.00%
ROA
-32.40%
Debt/equity
12.22x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2015$17.23M$-22.97M27.38%-119.12%-133.32%
2016$15.60M$-21.85M33.13%-121.36%-140.04%
2017$21.30M$-17.84M42.95%-81.15%-83.78%
2018$21.96M$-28.73M43.30%-117.99%-130.83%
2019$110.41M$-42.30M69.43%-18.37%-38.31%
2020$78.01M$-82.82M65.87%-51.85%-106.16%
2021$105.62M$-22.14M70.15%-16.61%-20.96%
2022$99.50M$-43.70M66.30%-35.05%-43.92%
2023$76.35M$-37.25M68.32%-37.08%-48.79%
2024$64.83M$-47.00M68.34%-41.93%-72.49%

Frequently asked questions

What is Venus Concept Inc's revenue?

Venus Concept Inc's trailing twelve-month revenue is $58.88M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is VERO?

In its most recent fiscal year, VERO ran a gross margin of 68.34%, an operating margin of -41.93%, and a net margin of -72.49%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does VERO generate?

VERO produced $-11.19M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is VERO's balance sheet healthy?

VERO holds $4.27M in cash and equivalents against $31.44M in long-term debt, on $2.37M of shareholder equity. That debt is best read against the cash flow the business throws off each year.